Movano (Movano) EBIT per Share : $-0.66 (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Movano EBIT per Share?

Movano's EBIT per Share for the three months ended in Dec. 2023 was $-0.11. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.66.

During the past 3 years, the average EBIT per Share Growth Rate was -19.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Movano's EBIT per Share or its related term are showing as below:

MOVE' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -23 Med: -21.3 Max: -19.6
Current: -19.6

During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of Movano was -19.60% per year. The lowest was -23.00% per year. And the median was -21.30% per year.

MOVE's 3-Year EBIT Growth Rate is ranked worse than
80.25% of 724 companies
in the Medical Devices & Instruments industry
Industry Median: 6.75 vs MOVE: -19.60

Movano's EBIT for the three months ended in Dec. 2023 was $-6.02 Mil.

Movano EBIT per Share Historical Data

The historical data trend for Movano's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Movano EBIT per Share Chart

Movano Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-0.49

-0.41

-0.79

-0.92

-0.64

Movano Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT per Share	Get a 7-Day Free Trial													-0.24	-0.19	-0.17	-0.18	-0.11

Movano EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Movano's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-29.69	/	46.195
=	-0.64

Movano's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-6.024	/	53.328
=	-0.11

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.66

Movano (NAS:MOVE) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Movano EBIT per Share Related Terms

Thank you for viewing the detailed overview of Movano's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Movano (Movano) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Movano Inc (NAS:MOVE) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

6800 Koll Center Parkway, Pleasanton, CA, USA, 94566

Website

https://www.movano.com

Movano Inc is a health-focused technology company developing simple, smart, and personalized devices designed to help individuals on their health journey maintain good health today and prevent and manage chronic diseases in the future. It is developing a proprietary platform that uses Radio Frequency (RF) technology. It enables the creation of low-cost and scalable sensors that fit into wearable and other small form factors.

Executives

Jeremy Cogan	officer: CFO	6800 KOLL CENTER PARKWAY, PLEASANTON CA 94566
Michael Aaron Leabman	director, officer: CEO and President	207 VERITAS CT, SAN RAMON CA 94582
Emily Fairbairn	director	10 ORINDA VIEW ROAD, ORINDA CA 94563
John Mastrototaro	director	6800 KOLL CENTER PARKWAY, PLEASANTON CA 94566
Brian Cullinan	officer: CFO	6800 KOLL CENTER PARKWAY, PLEASANTON CA 94566
Nan Kirsten Forte	director	111 EIGHTH AVENUE, NEW YORK NY 10011
Ruben Caballero	director	C/O RESONANT INC. 10900 STONELAKE BLVD., SUITE 100, OFFICE 02-130, AUSTIN TX 78759
Dvine Irrevocable Trust	10 percent owner	6200 STONERIDGE MALL RD., SUITE 300, PLEASANTON CA 94588
Gregory S Tamkin	10 percent owner	303 RAY STREET, PLEASANTON CA 94566
Dorsey & Whitney Trust Co Llc	10 percent owner	401 EAST EIGHTH STREET, SUITE 319, SIOUX FALLS SD 57103
William Tai-wei Ho	10 percent owner	C/O IN8BIO, INC., 79 MADISON AVENUE, NEW YORK NY 10016